We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 100 consecutive patients with limited- and extensive-disease small-cell lung cancer.
- Authors
Fetscher, S; Brugger, W; Engelhardt, R; Kanz, L; Hasse, J; Frommhold, H; Wenger, M; Lange, W; Mertelsmann, R
- Abstract
We conducted a phase I/II trial to assess the feasibility and activity of VIP-E chemotherapy in small-cell lung cancer. End-points were treatment-related morbidity and mortality, response to treatment. duration of response, and survival.
- Publication
Annals of oncology : official journal of the European Society for Medical Oncology, 1997, Vol 8, Issue 1, p49
- ISSN
0923-7534
- Publication type
Journal Article
- DOI
10.1023/a:1008232329498